Hepatocellular Brg1 promotes CCl4-induced liver inflammation, ECM accumulation and fibrosis in mice.
Baocai WangBenedikt KaufmannCarolin MoglerSuyang ZhongYuhan YinZhangjun ChengRoland M SchmidHelmut FriessNorbert HüserGuido von FiguraDaniel HartmannPublished in: PloS one (2023)
Brg1 promotes the progression of liver fibrosis in mice and may therefore be used as a potential therapeutic target for treating patients with liver fibrosis due to chronic injury.